Data protection Impressum

Healthcare

Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGS Beteiligungen (EGSB) to fuel its next phase of growth and global expansion.

Spineart raises CHF 25 million to accelerate global expansion and innovation

6 October 2025

Geneva-based Multiwave Technologies has secured CHF 3.6 million to accelerate regulatory approval of its portable MRI device and establish a new assembly facility in the United States.

Multiwave raises CHF 3.6 million and opens US operations in Boston

1 October 2025

French robotics company Meanwhile has chosen Fribourg for its first international subsidiary, strengthening its presence in Switzerland and reinforcing its capacity to serve clients across the country.

Meanwhile opens its first international subsidiary in Fribourg

22 September 2025

Geneva-based EarlySight has raised an additional CHF 3.1 million, bringing its seed financing round to CHF 6.1 million, to launch its next-generation product and advance U.S. approval.

Retinal imaging specialist EarlySight raises CHF 3.1 million to accelerate global growth

10 September 2025

Four early-stage projects from UNIL and EPFL have each secured CHF 100,000 Tech Grants from the Foundation for Innovation and Technology (FIT) to advance their technologies.

FIT awards Tech Grants to four promising start-ups from UNIL and EPFL

9 September 2025

Bern-based medtech Rhovica Neuroimaging has secured CHF 2.3 million to accelerate development of its SoNav system for safer emergency neurosurgery.

Rhovica raises CHF 2.3 million to advance bedside neurosurgery navigation

2 September 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (August 2025)

1 September 2025

A study by CHUV and UNIGE published in Nature Neuroscience shows that virtual reality scenarios can activate the human immune system in the absence of real pathogens.

CHUV and UNIGE study shows virtual reality can trigger an immune response

20 August 2025

Pilatus Biosciences launches first-in-human trial in collaboration with Roche

20 August 2025

Researchers from HUG and UNIGE have developed patient-derived lung cancer “mini-tumors” to rapidly identify the most effective personalized treatments.

Geneva team develops lung cancer “mini-tumors” to accelerate personalized treatments

13 August 2025

1 2 3 4 5 … 21